Sensor-Based Digital Therapeutics Devices Market

Software is estimated to account for 41.8% of 2026 demand, while hospital is projected to represent 28.0% by care setting and monitoring is anticipated to capture 14.0% by application. Clinical integration and post-market evidence requirements delay repeat deployment across health systems with different oversight and workflow structures.